| abstract |
New carnitine derivatives are described having the general formula (I):n wherein A = H, -(CH₂) n -O-CO-R₁, n being 1 or 2, and B = -(CH₂) m -O-CO-R₂, m being 1, 2, 3,4 with the limitation that when A = -(CH₂) n -O-CO-R₁, m is 1 or 2, and in which R₁ and R₂, equal or different are radicals of aliphatic, aromatic, araliphatic, alicyclic or heterocyclic acids. n The process for preparing said derivatives is also described and their use in the therapy of human pathologies associated with neuronal damages. |